Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Formula: C44H42F3N7O12
11-pentaene-27-carboxamide
Chemical Name: 3-(4-methoxypyridine-3-carbonyl)-1-[2-(trifluoromethyl)-[1
PubMed PMID: 9020426
with a pharmacokinetic profile enabling long-acting drug efficacy
Saxagliptin hydrate esceinamine Isomer II Formula: C44H42F3N7O12Saxagliptin, also known as BMS 477118, is a new oral hypoglycemic (anti diabetic drug) of the new dipeptidyl peptidase 4 (DPP 4) inhibitor class of drugs. Saxagliptin was approved in 2008 for the treatment of type 2 diabetes. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose